Crossref
journal-article
Springer Science and Business Media LLC
Nature Materials (297)
References
38
Referenced
452
-
Chan, W. C. & Nie, S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281, 2016–2018 (1998).
(
10.1126/science.281.5385.2016
) / Science by WC Chan (1998) -
Park, J. H. et al. Magnetic iron oxide nanoworms for tumour targeting and imaging. Adv. Mater. 20, 1630–1630 (2008).
(
10.1002/adma.200800004
) / Adv. Mater. by JH Park (2008) -
Xia, Y. N. & Halas, N. J. Shape-controlled synthesis and surface plasmonic properties of metallic nanostructures. MRS Bull. 30, 338–344 (2005).
(
10.1557/mrs2005.96
) / MRS Bull. by YN Xia (2005) -
Gref, R. et al. Biodegradable long-circulating polymeric nanospheres. Science 263, 1600–1603 (1994).
(
10.1126/science.8128245
) / Science by R Gref (1994) -
Sengupta, S. et al. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature 436, 568–572 (2005).
(
10.1038/nature03794
) / Nature by S Sengupta (2005) -
Park, J. H., von Maltzahn, G., Ruoslahti, E., Bhatia, S. N. & Sailor, M. J. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew. Chem. Int. Ed. 47, 7284–7288 (2008).
(
10.1002/anie.200801810
) / Angew. Chem. Int. Ed. by JH Park (2008) -
Litzinger, D. C. & Huang, L. Phosphatidylethanolamine liposomes—drug delivery, gene-transfer and immunodiagnostic applications. Biochim. Biophys. Acta 1113, 201–227 (1992).
(
10.1016/0304-4157(92)90039-D
) / Biochim. Biophys. Acta by DC Litzinger (1992) -
Akinc, A. et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nature Biotechnol. 26, 561–569 (2008).
(
10.1038/nbt1402
) / Nature Biotechnol. by A Akinc (2008) -
Anderson, D. G., Lynn, D. M. & Langer, R. Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew. Chem. Int. Ed. 42, 3153–3158 (2003).
(
10.1002/anie.200351244
) / Angew. Chem. Int. Ed. by DG Anderson (2003) -
Leserman, L. D., Barbet, J., Kourilsky, F. & Weinstein, J. N. Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A. Nature 288, 602–604 (1980).
(
10.1038/288602a0
) / Nature by LD Leserman (1980) -
Heath, T. D., Fraley, R. T. & Papahdjopoulos, D. Antibody targeting of liposomes: Cell specificity obtained by conjugation of F(ab′)2 to vesicle surface. Science 210, 539–541 (1980).
(
10.1126/science.7423203
) / Science by TD Heath (1980) -
Akerman, M. E., Chan, W. C. W., Laakkonen, P., Bhatia, S. N. & Ruoslahti, E. Nanocrystal targeting in vivo. Proc. Natl Acad. Sci. USA 99, 12617–12621 (2002).
(
10.1073/pnas.152463399
) / Proc. Natl Acad. Sci. USA by ME Akerman (2002) -
Hood, J. D. et al. Tumour regression by targeted gene delivery to the neovasculature. Science 296, 2404–2407 (2002).
(
10.1126/science.1070200
) / Science by JD Hood (2002) -
Farokhzad, O. C. et al. Nanoparticle–aptamer bioconjugates: A new approach for targeting prostate cancer cells. Cancer Res. 64, 7668–7672 (2004).
(
10.1158/0008-5472.CAN-04-2550
) / Cancer Res. by OC Farokhzad (2004) -
Weissleder, R., Kelly, K., Sun, E. Y., Shtatland, T. & Josephson, L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nature Biotechnol. 23, 1418–1423 (2005).
(
10.1038/nbt1159
) / Nature Biotechnol. by R Weissleder (2005) -
Geng, Y. et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nature Nanotech. 2, 249–255 (2007).
(
10.1038/nnano.2007.70
) / Nature Nanotech. by Y Geng (2007) -
Moghimi, S. M., Hunter, A. C. & Murray, J. C. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev. 53, 283–318 (2001).
(
10.1016/S0031-6997(24)01494-7
) / Pharmacol. Rev. by SM Moghimi (2001) -
Moghimi, S. M. & Szebeni, J. Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties. Progr. Lipid Res. 42, 463–478 (2003).
(
10.1016/S0163-7827(03)00033-X
) / Progr. Lipid Res. by SM Moghimi (2003) -
Murphy, C. J. et al. Anisotropic metal nanoparticles: Synthesis, assembly, and optical applications. J. Phys. Chem. B 109, 13857–13870 (2005).
(
10.1021/jp0516846
) / J. Phys. Chem. B by CJ Murphy (2005) -
Jain, P. K., Lee, K. S., El-Sayed, I. H. & El-Sayed, M. A. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: Applications in biological imaging and biomedicine. J. Phys. Chem. B 110, 7238–7248 (2006).
(
10.1021/jp057170o
) / J. Phys. Chem. B by PK Jain (2006) -
Hu, M. et al. Gold nanostructures: Engineering their plasmonic properties for biomedical applications. Chem. Soc. Rev. 35, 1084–1094 (2006).
(
10.1039/b517615h
) / Chem. Soc. Rev. by M Hu (2006) - Kong, G., Braun, R. D. & Dewhirst, M. W. Hyperthermia enables tumour-specific nanoparticle delivery: Effect of particle size. Cancer Res. 60, 4440–4445 (2000). / Cancer Res. by G Kong (2000)
-
von Maltzahn, G. et al. Computationally-guided photothermal tumour therapy using long-circulating gold nanorod antennas. Cancer Res. 69, 3892–3900 (2009).
(
10.1158/0008-5472.CAN-08-4242
) / Cancer Res. by G von Maltzahn (2009) -
Hashizume, H. et al. Openings between defective endothelial cells explain tumour vessel leakiness. Am. J. Pathol. 156, 1363–1380 (2000).
(
10.1016/S0002-9440(10)65006-7
) / Am. J. Pathol. by H Hashizume (2000) -
Maeda, H. The enhanced permeability and retention (EPR) effect in tumour vasculature: The key role of tumour-selective macromolecular drug targeting. Adv. Enzyme Regul. 41, 189–207 (2001).
(
10.1016/S0065-2571(00)00013-3
) / Adv. Enzyme Regul. by H Maeda (2001) -
Weissleder, R. A clearer vision for in vivo imaging. Nature Biotechnol. 19, 316–317 (2001).
(
10.1038/86684
) / Nature Biotechnol. by R Weissleder (2001) -
Kessler, T. et al. Inhibition of tumour growth by RGD peptide-directed delivery of truncated tissue factor to the tumour vasculature. Clin. Cancer Res. 11, 6317–6324 (2005).
(
10.1158/1078-0432.CCR-05-0389
) / Clin. Cancer Res. by T Kessler (2005) -
Bieker, R. et al. Infarction of tumour vessels by NGR-peptide directed targeting of tissue factor. Experimental results and first-in-man experience. Blood 113, 5019–5027 (2009).
(
10.1182/blood-2008-04-150318
) / Blood by R Bieker (2009) -
Huang, X. M. et al. Tumour infarction in mice by antibody-directed targeting of tissue factor to tumour vasculature. Science 275, 547–550 (1997).
(
10.1126/science.275.5299.547
) / Science by XM Huang (1997) -
El-Sheikh, A., Borgstrom, P., Bhattacharjee, G., Belting, M. & Edgington, T. S. A selective tumour microvasculature thrombogen that targets a novel receptor complex in the tumour angiogenic microenvironment. Cancer Res. 65, 11109–11117 (2005).
(
10.1158/0008-5472.CAN-05-2733
) / Cancer Res. by A El-Sheikh (2005) -
Persigehl, T. et al. Antiangiogenic tumour treatment: Early noninvasive monitoring with USPIO-enhanced MR imaging in mice. Radiology 244, 449–456 (2007).
(
10.1148/radiol.2442060371
) / Radiology by T Persigehl (2007) -
Paborsky, L. R., Caras, I. W., Fisher, K. L. & Gorman, C. M. Lipid association, but not the transmembrane domain, is required for tissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor. J. Biol. Chem. 266, 21911–21916 (1991).
(
10.1016/S0021-9258(18)54723-2
) / J. Biol. Chem. by LR Paborsky (1991) -
Jaffer, F. A. et al. Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi. Circulation 110, 170–176 (2004).
(
10.1161/01.CIR.0000134484.11052.44
) / Circulation by FA Jaffer (2004) -
Tung, C. H. et al. Novel factor XIII probes for blood coagulation imaging. Chembiochem 4, 897–899 (2003).
(
10.1002/cbic.200300602
) / Chembiochem by CH Tung (2003) -
Overoye-Chan, K. et al. EP-2104R: A fibrin-specific gadolinium-based MRI contrast agent for detection of thrombus. J. Am. Chem. Soc. 130, 6025–6039 (2008).
(
10.1021/ja800834y
) / J. Am. Chem. Soc. by K Overoye-Chan (2008) -
Isaacs, F. J., Dwyer, D. J. & Collins, J. J. RNA synthetic biology. Nature Biotechnol. 24, 545–554 (2006).
(
10.1038/nbt1208
) / Nature Biotechnol. by FJ Isaacs (2006) -
Hasty, J., McMillen, D. & Collins, J. J. Engineered gene circuits. Nature 420, 224–230 (2002).
(
10.1038/nature01257
) / Nature by J Hasty (2002) -
Jungmann, R., Renner, S. & Simmel, F. C. From DNA nanotechnology to synthetic biology. HFSP J. 2, 99–109 (2008).
(
10.2976/1.2896331
) / HFSP J. by R Jungmann (2008)
Dates
Type | When |
---|---|
Created | 14 years, 2 months ago (June 19, 2011, 2 p.m.) |
Deposited | 5 months, 3 weeks ago (March 6, 2025, 5:33 a.m.) |
Indexed | 1 week ago (Aug. 26, 2025, 2:44 a.m.) |
Issued | 14 years, 2 months ago (June 19, 2011) |
Published | 14 years, 2 months ago (June 19, 2011) |
Published Online | 14 years, 2 months ago (June 19, 2011) |
Published Print | 14 years, 2 months ago (July 1, 2011) |
@article{von_Maltzahn_2011, title={Nanoparticles that communicate in vivo to amplify tumour targeting}, volume={10}, ISSN={1476-4660}, url={http://dx.doi.org/10.1038/nmat3049}, DOI={10.1038/nmat3049}, number={7}, journal={Nature Materials}, publisher={Springer Science and Business Media LLC}, author={von Maltzahn, Geoffrey and Park, Ji-Ho and Lin, Kevin Y. and Singh, Neetu and Schwöppe, Christian and Mesters, Rolf and Berdel, Wolfgang E. and Ruoslahti, Erkki and Sailor, Michael J. and Bhatia, Sangeeta N.}, year={2011}, month=jun, pages={545–552} }